Prevention of adverse effects caused by cd3 specific binding domains
- 专利权人:
- AMGEN RESEARCH (MUNICH) GMBH
- 发明人:
- ZUGMAIER GERHARD,NAGORSEN DIRK,SCHEELE JUERGEN
- 申请号：
- NZ61003411
- 公开号：
- NZ610034A
- 申请日:
- 2011.10.27
- 申请国别(地区):
- NZ
- 年份:
- 2015
- 代理人:
- 摘要：
- Discloses the use of a glucocorticoid (GC) in the preparation of a medicament for the amelioration, treatment or prophylaxis of a neurological adverse event in a patient caused by the administration of a CD3 binding domain.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- USE OF AN ANTI-CD71 ANTIBODY FOR PREPARING A MEDICAMENT
- Use of one or more hbv antigens for the preparation of oral pharmaceutical compositions for treating a subject having an active hbv infection or hepatocellular carcinoma
- Use of one or more hbv antigens for the preparation of oral pharmaceutical compositions for treating a subject having an active hbv infection or hepatocellular carcinoma
- Use of one or more hbv antigens for the preparation of oral pharmaceutical compositions for treating a subject having an active hbv infection or hepatocellular carcinoma
- PREPARATIONS OF SINGLE DOMAIN ANTIGEN-BINDING MOLECULES
